|Articles|July 1, 2012

Applied Clinical Trials

  • Applied Clinical Trials-07-01-2012
  • Volume 21
  • Issue 7

Supply Chain Management

Tufts CSDD

The role of clinical supply chain management is changing dramatically. Historically a function that is engaged after a study's clinical operations strategy has been established, clinical supply professionals are now playing a more active role in development, study strategy, planning, managing mission critical activities, and in forecasting and mitigating operating risk. To assess this evolving role, the Tufts Center for the Study of Drug Development surveyed 20 senior level executives in large- and mid-sized biopharmaceutical companies. The executives surveyed note that forecasting and risk management has moved to the forefront of their functional responsibilities and as key requirements for study success. Ensuring timely delivery and availability of supplies and investigational drugs for study volunteers has become far more demanding as clinical trials have become globally disbursed and cost pressures have reduced study drug overproduction and clinical supplies inventory.

Despite the importance of accurate supply forecasting and planning, most respondents report using relatively unsophisticated approaches: Excel spreadsheets; in-house forecasting programs; and commercially-available web-based approaches.

The most demanding clinical supply management requirements.

—Tufts Center for the Study of Drug Development, http://csdd.tufts.edu.

Articles in this issue


Related to this article

© photon_photo - © photon_photo - stock.adobe.com
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.